Best TWAS P=7.49e-11 · Best GWAS P=1.27e-11 conditioned to 0.0205
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Artery Coronary | FLVCR1-AS1 | 0.43 | 0.45 | lasso | 12 | 0.44 | 2.8e-16 | -5.0 | 5.2 | 1.9e-07 | -0.69 | 0.68 | 0.32 | FALSE |
2 | GTEx | Artery Coronary | TATDN3 | 0.22 | 0.04 | lasso | 11 | 0.07 | 2.2e-03 | -6.1 | -5.4 | 8.0e-08 | 0.74 | 0.05 | 0.80 | FALSE |
3 | GTEx | Brain Hypothalamus | FLVCR1-AS1 | 0.72 | 0.62 | lasso | 7 | 0.63 | 1.2e-18 | -5.0 | 5.2 | 2.0e-07 | -0.69 | 0.93 | 0.07 | FALSE |
4 | GTEx | Breast Mammary Tissue | FLVCR1-AS1 | 0.45 | 0.44 | enet | 21 | 0.44 | 1.6e-24 | -5.0 | 5.2 | 1.6e-07 | -0.70 | 0.97 | 0.03 | FALSE |
5 | GTEx | Breast Mammary Tissue (Male) | FLVCR1-AS1 | 0.52 | 0.39 | lasso | 8 | 0.44 | 2.2e-11 | -6.2 | 5.9 | 4.5e-09 | -0.83 | 0.09 | 0.91 | FALSE |
6 | GTEx | Cells Transformed fibroblasts | TATDN3 | 0.11 | 0.12 | lasso | 2 | 0.10 | 3.2e-08 | -6.2 | -6.2 | 7.8e-10 | 0.92 | 0.05 | 0.95 | FALSE |
7 | GTEx | Colon Sigmoid | FLVCR1-AS1 | 0.55 | 0.55 | enet | 11 | 0.49 | 1.8e-19 | -5.0 | 5.2 | 2.1e-07 | -0.74 | 0.93 | 0.07 | FALSE |
8 | GTEx | Colon Transverse | TATDN3 | 0.26 | 0.02 | lasso | 7 | 0.02 | 2.8e-02 | -6.4 | -5.3 | 1.2e-07 | 0.64 | 0.05 | 0.93 | FALSE |
9 | GTEx | Esophagus Gastroesophageal Junction | TATDN3 | 0.27 | 0.08 | enet | 29 | 0.11 | 7.1e-05 | -6.0 | -5.6 | 2.2e-08 | 0.70 | 0.10 | 0.87 | FALSE |
10 | GTEx | Esophagus Mucosa | FLVCR1-AS1 | 0.33 | 0.47 | enet | 16 | 0.46 | 4.7e-34 | -5.0 | 5.1 | 3.0e-07 | -0.72 | 0.97 | 0.03 | FALSE |
11 | GTEx | Esophagus Muscularis | FLVCR1-AS1 | 0.52 | 0.53 | enet | 32 | 0.54 | 5.4e-38 | -5.0 | 5.4 | 5.8e-08 | -0.73 | 0.97 | 0.03 | FALSE |
12 | GTEx | Heart Atrial Appendage | FLVCR1-AS1 | 0.56 | 0.61 | enet | 12 | 0.58 | 8.7e-32 | -5.0 | 5.5 | 3.9e-08 | -0.71 | 0.98 | 0.02 | FALSE |
13 | GTEx | Lung | FLVCR1-AS1 | 0.42 | 0.50 | lasso | 5 | 0.52 | 4.9e-46 | -5.0 | 5.5 | 3.4e-08 | -0.75 | 0.97 | 0.03 | FALSE |
14 | GTEx | Muscle Skeletal | FLVCR1-AS1 | 0.28 | 0.28 | enet | 22 | 0.27 | 1.3e-26 | -5.0 | 5.3 | 1.3e-07 | -0.69 | 0.97 | 0.03 | FALSE |
15 | GTEx | Ovary | FLVCR1-AS1 | 0.47 | 0.20 | enet | 15 | 0.20 | 1.1e-05 | -5.0 | 5.7 | 1.4e-08 | -0.78 | 0.08 | 0.81 | FALSE |
16 | GTEx | Prostate | FLVCR1-AS1 | 0.40 | 0.36 | lasso | 3 | 0.36 | 4.5e-10 | -5.0 | 5.6 | 2.1e-08 | -0.77 | 0.08 | 0.91 | FALSE |
17 | GTEx | Spleen | FLVCR1-AS1 | 0.63 | 0.54 | lasso | 8 | 0.55 | 5.9e-17 | -5.0 | 5.3 | 1.0e-07 | -0.76 | 0.23 | 0.77 | FALSE |
18 | GTEx | Stomach | FLVCR1-AS1 | 0.30 | 0.36 | lasso | 3 | 0.36 | 7.0e-18 | -5.0 | 5.5 | 5.1e-08 | -0.75 | 0.84 | 0.16 | FALSE |
19 | GTEx | Thyroid | FLVCR1-AS1 | 0.48 | 0.44 | lasso | 7 | 0.46 | 8.8e-39 | -5.0 | 5.1 | 2.8e-07 | -0.73 | 0.97 | 0.03 | FALSE |
20 | GTEx | Whole Blood | TATDN3 | 0.06 | 0.07 | enet | 6 | 0.07 | 1.2e-06 | -6.4 | -6.5 | 7.5e-11 | 0.86 | 0.02 | 0.98 | TRUE |
21 | METSIM | Adipose | TATDN3 | 0.13 | 0.08 | lasso | 5 | 0.17 | 4.0e-25 | -6.3 | -5.3 | 1.1e-07 | 0.69 | 0.04 | 0.96 | FALSE |
22 | The Cancer Genome Atlas | Breast Invasive Carcinoma | TATDN3 | 0.04 | 0.01 | blup | 49 | 0.01 | 1.1e-03 | -6.8 | -5.8 | 6.0e-09 | 0.75 | 0.00 | 0.98 | FALSE |
23 | The Cancer Genome Atlas | Colon Adenocarcinoma | LQK1 | 0.56 | 0.58 | enet | 11 | 0.59 | 4.5e-42 | -5.0 | 5.1 | 2.9e-07 | -0.70 | 0.97 | 0.03 | FALSE |
24 | The Cancer Genome Atlas | Glioblastoma Multiforme | LQK1 | 0.61 | 0.45 | enet | 6 | 0.41 | 9.0e-14 | -5.0 | 5.2 | 1.9e-07 | -0.71 | 0.95 | 0.05 | FALSE |
25 | The Cancer Genome Atlas | Brain Lower Grade Glioma | TATDN3 | 0.08 | 0.02 | lasso | 5 | 0.05 | 2.3e-06 | -6.2 | -5.7 | 9.6e-09 | 0.78 | 0.01 | 0.98 | FALSE |
26 | The Cancer Genome Atlas | Lung Adenocarcinoma | LQK1 | 0.57 | 0.62 | lasso | 8 | 0.63 | 9.6e-95 | -5.1 | 5.1 | 2.9e-07 | -0.71 | 0.97 | 0.03 | FALSE |
27 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | C1orf227 | 0.02 | 0.01 | blup | 48 | 0.01 | 1.5e-02 | -5.0 | 6.1 | 1.2e-09 | -0.84 | 0.02 | 0.68 | FALSE |
28 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | LQK1 | 0.55 | 0.59 | enet | 12 | 0.60 | 3.6e-50 | -5.0 | 5.1 | 2.7e-07 | -0.71 | 0.97 | 0.03 | FALSE |
29 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | TATDN3 | 0.10 | 0.04 | lasso | 6 | 0.08 | 6.4e-04 | -6.2 | -6.1 | 1.4e-09 | 0.83 | 0.01 | 0.77 | FALSE |
30 | The Cancer Genome Atlas | Prostate Adenocarcinoma | FLVCR1 | 0.09 | 0.03 | blup | 62 | 0.03 | 7.6e-04 | -4.5 | -5.3 | 1.5e-07 | 0.63 | 0.23 | 0.34 | FALSE |
31 | The Cancer Genome Atlas | Stomach Adenocarcinoma | LQK1 | 0.57 | 0.62 | enet | 17 | 0.61 | 3.5e-55 | -5.1 | 5.4 | 7.9e-08 | -0.74 | 0.96 | 0.03 | FALSE |
32 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | LQK1 | 0.77 | 0.47 | lasso | 7 | 0.43 | 2.1e-13 | -5.0 | 5.3 | 1.1e-07 | -0.73 | 0.65 | 0.35 | FALSE |